Sep 24, 2014
We did it!
There were only five of us on Team Crain this year, but we crushed it. We managed to raise $6,695 bucks to fight leukemia, lymphoma and other blood cancers. There's still time to donate! And every single dollar above the goal goes straight to research and such. No race costs or administrative costs built in.
- Ken, Natalie, Tracy, Becky, Abbey
While the race course in Philly is beautiful and flat, the weather was hellacious. Humidity was between 80% and 90% and that's no fun for anyone. But that didn't stop team members Natalie Zmuda Tucker and Abbey Klaassen from setting their own personal records. Natalie also came in first on the team.
This wasn't an official race for the New York chapter, so we traveled on our own without the usual cheering squad. But the thing about wearing TNT purple is cheering squads will find you. The Philly chapter staffed the water station just after mile four. More importantly, a couple of coaches -- one from D.C. and one from the Philly area -- ran with our runners in the last three miles of the race. Like angels did they appear. So Chris, Mike and Maureen, if you're reading this, thank you.
Thanks to the coaching staff of TNT Brooklyn and TNT Westchester/Connecticut for help through the season. And, of course, thanks to our donors, including the Crain Family Foundation.
Jun 17, 2014
It's summer time, so that means a dedicated team of Crain Communications/Advertising Age employees are sweating it out for Team in Training. The goal? To train for the Philadelphia Rock n Roll Half Marathon and, more important, to raise money to fight blood cancers.
In the five years that Crain Communications and its employees have been fielding a Team in Training team, we've raised over $130,000 to help The Leukemia & Lymphoma Society find cures and more effective treatment for leukemia, lymphoma, Hodgkin’s disease and myeloma.
Since TNT's founding over 25 years ago, more than 570,000 participants have helped LLS invest more than $875 million directly into blood cancer research (and raised a total of over $1.2 billion). That's actual dollars invested in actual research and patient and family support. Want to know what kind of difference that makes?
The above video explains some mind-bending ongoing research at MSKCC that Team Captain Ken Wheaton had a chance to check out on a TNT lab tour earlier this year. You can read more about that here.
Of 67 new cancer drugs approved by the F.D.A since 2000, almost half (28) were approved as treatments for blood cancer patients. All of these were advanced with LLS support. Many have been approved or are commonly used for additional cancer patients, including for solid tumor patients. And most of the 28 are being tested for other patients.
An LLS-funded researcher developed Gleevec, a pill for Chronic Myelogenous Leukemia. Now, more than 95 percent of newly diagnosed CML patients survive more than five years with a good quality of life. LLS was also instrumental in the development of Velcade, a targeted treatment approved for patients with multiple myeloma and mantle cell lymphoma.
In 1964 the 5 year survival rate for a child with ALL, the most common type of childhood leukemia, was 3%. Today it’s a little over 90%.
But that leaves 10%. A heartbreaking 10%
So donate now. Or join your local TNT chapter today.
You donate. We run. LLS gets funds. Cancer-survivors and their families have their lives made longer or even just a little easier. We all win.
The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.